Komori
Gmo Prime Strategy (5250) · RiskFirst stated

Risk of Deficiencies in Internal Controls over Financial Reporting

First written in FY2022. . Latest entry: FY2022.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Deficiencies in Internal Control over Financial ReportingA theme 30 companies write about · 30 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2023: 2 of 9 companies on the "Worse" side.

8 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 30 companies compared. The sentences above are computed from all 30.
Full recordFilings, disclosures and news, newest first
  1. FY2022First statedAnnual report

    「Because internal controls inherently have inherent limitations, if the Group's internal controls over financial reporting fail to function effectively in the future, or if a material deficiency arises in those controls, this could have a certain impact on the reliability of the Group's financial reporting.」

    The company positions internal controls relating to the reliability of financial reporting as a key management issue and states that it will continue to inspect and improve them.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Gmo Prime Strategy yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Deficiencies in Internal Controls over Financial Reporting | GMO PRIME STRATEGY CO.,LTD. (5250) | Komori